Gino Martini Chief Scientist

PharmSci Yesterday

We've recorded a lot of PharmSci Today podcasts, with movers and shakers from  across pharmaceutical science. Below are some of the older episodes...

Apple_Podcasts_Listen_Badge_RGB Google_podcasts_Listen_Badge_RGB
Stitcher_Listen_Badge_Color_Dark_BG_MATCHED Spotify_Podcast_Badge_RGB

feed-icon-28x28 Remember, you can subscribe to PharmSci today with your app of choice (copy this link to our podcast RSS feed into your preferred app).

RPS PharmSci Today #20

November 2020

RPS Chief Scientist Professor Gino Martini speaks to Dr Clive Dix, Deputy Chair of the UK's Vaccine Taskforce.

They look at the UK's plans for developing a COVID-19 vaccine: the different options and likelihood of success, as well as the difficulties in storing and distributing vaccines.

PharmSci Today #19 (part 2)

Gino and Sarah continue their chat with Oksana Pyzik, UCL Lead of Global Citizenship Programme on Outbreaks of Infectious Diseases.

Oksana is one of the creators of Fight the Fakes, a campaign to raise awareness about the dangers of fake medicines, which is more important than ever while the COVID-19 pandemic continues.

PharmSci Today #19 (part 1)

Join Gino and Sarah for the first part of their chat with Oksana Pyzik, UCL Lead of Global Citizenship Programme on Outbreaks of Infectious Diseases.

Oksana is one of the creators of Fight the Fakes, a campaign to raise awareness about the dangers of fake medicines, which is more important than ever while the COVID-19 pandemic continues.

PharmSci Today #18

Gino and Sarah talk to Dave Tudor, Managing Director of the Medicines Manufacturing Innovation Centre at CPI (Centre for Process Innovation).

As the COVID-19 pandemic continues they look at how the pharmaceutical industry has accelerated and innovated its processes, responding like never before to this global crisis.

PharmSci Today #17

Gino and Sarah talk to Dr Daria Donati, Head of Business Development & Strategic Technology Partnerships at Cytiva.

They discuss the prospects for a COVID-19 vaccine in the UK supported by VMIC, the Vaccines Manufacturing and Innovation Centre, which is supporting the development and manufacture of UK vaccines.

PharmSci Today #16

Gino and Sarah talk to Chas Bountra, Professor of Translational Medicine in the Nuffield Department of Clinical Medicine and Associate Member of the Department of Pharmacology at the University of Oxford.

The first working COVID vaccine could come from Oxford, and Professor Bountra discusses the secret of the city's success in the fight against the pandemic.

PharmSci Today #15

Gino and Sarah talk to Warwick Smith, Director General of the British Generic Manufacturers Association, about the effects COVID-19 has had on the pharmaceutical industry, as well as when and how a vaccine or treatment is likely to become available.

PharmSci Today #13

Gino and Sarah talk to Dr Brian Henry, Vice President, Drug Product Design at Pfizer.

Join them and discover how research into COVID-19 vaccines and treatments is progressing, as well as how pharmacy in general R&D has changed post-COVID.

Sheuli

PharmSci Today #12

Gino and Sarah Cahill talk to Dr Sheuli Porkess, Executive Director for Research, Medicine and Innovation at the Association of the British Pharmaceutical Industry.

They discuss some of the remarkable research efforts currently underway to find treatments and a vaccine for COVID-19.

PharmSci Today #11

Gino and Sarah Cahill chat with Roz Gittins of Humankind and Dr Amira Guirguis of Swansea University Medical School, about substance misuse issues during the COVID-19 pandemic.

PharmSci Today #10

In episode 10 of the PharmSci Today podcast, Haseeb Ahmad, Managing Director, UK, Ireland & Nordics Novartis Pharmaceuticals and Country President Novartis UK and President of the ABPI is interviewed by Paul Bennett (CEO, RPS), Prof Gino Martini (Chief Scientist, RPS) and Sarah Cahill (Chief Pharmaceutical Officer's Clinical Fellow) about the Novartis response to COVID-19.

In addition, Haseeb Ahmad also provides insight into the response to COVID-19 by the Pharmaceutical Industry. 

In this podcast, we will cover experimental vaccines and a few existing medicines that are approved for other indications. The RPS, Novartis and the ABPI want to be very clear that they are not endorsing use of these medicines and no treatments have been approved for COVID-19. Their intent is to explain to the society’s listeners the current status of the various clinical studies which are ongoing.

PharmSci Today #9

In episode 09 of the PharmSci Today podcast, Paul Bennett (CEO, RPS), Prof Gino Martini (RPS Chief Scientist) and Sarah Cahill (Clinical Fellow, RPS) talk to Richard Saynor (CEO, Sandoz).

Richard discusses Sandoz’s response to COVID-19 and how they are maintaining supply chains and supporting clinical trials to combat the coronavirus. Sandoz is one of the largest suppliers of generic medicines in the world and a separate division of Novartis.

Gino talks to Dr Hubert Bland from pharmaceutical company Sanofi, discussing the prospects for coronavirus treatments and vaccines.

In this podcast, Sanofi will talk about experimental vaccines and a few existing medicines that are approved for other indications. Sanofi wants to be very clear that use of any of its medicines in COVID-19 is off-label, entirely experimental at this stage – therefore unproven. Sanofi wants to caution they are not endorsing use of these medicines. Their intent is to explain to the society’s listeners the current status of these studies.

PharmSci Today #08

New developments in pharmaceutical science, with Professor Gino Martini, Chief Scientist at the Royal Pharmaceutical Society.

Gino talks to Dr Hubert Bland from pharmaceutical company Sanofi, discussing the prospects for coronavirus treatments and vaccines.

In this podcast, Sanofi will talk about experimental vaccines and a few existing medicines that are approved for other indications. Sanofi wants to be very clear that use of any of its medicines in covid-19 is off-label, entirely experimental at this stage – therefore unproven. Sanofi wants to caution they are not endorsing use of these medicines. Their intent is to explain to the society’s listeners the current status of these studies.

PharmSci Today #7

Gino talks to RPS Director of Pharmacy and Member Experience, Robbie Turner, about the threat of coronavirus and looks at the prospects for treatments and a vaccine.

PharmSci Today #6

Gino talks to Professor David Taylor, Professor Emeritus of Pharmaceutical and Public Health Policy at UCL, about the role of pharmacists in the NHS, the effects of Brexit and investing in the future of healthcare.

PharmSci Today #5

This month, Helena Rosado of the RPS sits in for Professor Martini. She speaks to Dr Janet Halliday, RPS Fellow and Associate Vice President, FCT and External Technology at Ferring Pharmaceuticals.

Find out what's new in: 

  • Industrial pharmacy
  • Women's health 
  • and drug delivery systems.

PharmSci Today #4

AmiraGuiguis

Gino introduces Dr Amira Guirguis talking about Novel Psychoactive Substances.

This interview was recorded at Swansea as part of the Exploring Global Problems podcast series from Swansea University, where Dr Guirguis is based.

You can also listen to this podcast on Spotify, Apple and Google.

PharmSci Today #3

Professor Martini talks with Christine Bond, Professor of Primary Care at the University of Aberdeen and also Editor in Chief of the International Journal of Pharmacy Practice.

  • How science underpins everything pharmacists do
  • The role of the Science Research Board (SRB) in the RPS

PharmSci Today #2

  • Proactive pharmacy - making a difference for patients
  • On the frontline: detecting AF and fighting AMR
  • Managing diabetes - what can you do?

PharmSci Today #1

  • Personalised medicine: the future of pharmacy?
  • CAR-T therapies: how are pharmacists involved?
  • The NHS Long-Term Plan for pharmacy.